Matthieu Ruffin
Impact in
-
- Pituitary Gland Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
-
- Neuroendocrine Tumor Research Advances
Papers in
-
- Pituitary Gland Disorders and Treatments 9
- Growth Hormone and Insulin-like Growth Factors 5
- Surgery 4
- Adrenal and Paraganglionic Tumors 4
- Co-authors
- Karina Hermosillo Reséndiz (4 shared papers)Pamela U. Freda (6 shared papers)Marcello D. Bronstein (6 shared papers)Andrew J. Farrall (5 shared papers)Mônica R. Gadelha (5 shared papers)Maria Fleseriu (5 shared papers)Annamaria Colao (4 shared papers)Feng Gu (2 shared papers)
- Journals
- Pituitary (2 papers)The Journal of Clinical Endocrinology & Metabolism (1 paper)European Journal of Endocrinology (1 paper)The Journal of Clinical Pharmacology (1 paper)BMC Endocrine Disorders (1 paper)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Matthieu Ruffin
10 papers receiving 535 citations
Peers
Comparison fields: 5 of 28
- Endocrinology, Diabetes and Metabolism 490
- Epidemiology 132
- Surgery 130
- Genetics 29
- Neurology 30
Countries citing papers authored by Matthieu Ruffin
This map shows the geographic impact of Matthieu Ruffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthieu Ruffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthieu Ruffin more than expected).
Fields of papers citing papers by Matthieu Ruffin
This network shows the impact of papers produced by Matthieu Ruffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthieu Ruffin. The network helps show where Matthieu Ruffin may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthieu Ruffin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 308 | |
| 2 | 2014 | 68 | |
| 3 | 2016 | 64 | |
| 4 | 2013 | 42 | |
| 5 | 2012 | 25 | |
| 6 | Pasireotide LAR is significantly more effective than octreotide LAR at inducing biochemical control in patients with acromegaly: results of a 12-month randomized, double-blind, multicenter, Phase III study | 2012 | 12 |
| 7 | 2012 | 8 | |
| 8 | 2013 | 7 | |
| 9 | Pasireotide (SOM230) effectively reduces pituitary tumor volume in patients with active acromegaly: preliminary 6-month results from a phase II extension study | 2008 | 6 |
| 10 | Pasireotide LAR vs octreotide LAR in patients with acromegaly: double-blind, crossover, extension period to a randomized, double-blind, multicenter, phase III study | 2012 | 3 |
About Matthieu Ruffin
Matthieu Ruffin is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Epidemiology, Genetics and Infectious Diseases, having authored 10 papers that have together received 543 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (9 papers), Growth Hormone and Insulin-like Growth Factors (5 papers), Adrenal and Paraganglionic Tumors (4 papers), Neuroendocrine Tumor Research Advances (2 papers) and Glioma Diagnosis and Treatment (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (490 citations), Epidemiology (132 citations), Surgery (130 citations), Genetics (29 citations) and Neurology (30 citations). Matthieu Ruffin has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Karina Hermosillo Reséndiz, Pamela U. Freda, Marcello D. Bronstein, Andrew J. Farrall, Mônica R. Gadelha, Maria Fleseriu, Annamaria Colao, Feng Gu, Chiung‐Chyi Shen and Mary N. Sheppard. Their work appears in journals such as Pituitary, The Journal of Clinical Endocrinology & Metabolism, European Journal of Endocrinology, The Journal of Clinical Pharmacology and BMC Endocrine Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.